CLINICAL_TRIALS
trial_result
· 2026-03-27
Clinical Trial Update: Phase I PK and Safety Study of Ondansetron Inhalation Powder [Phase 1]
Summary
Phase I PK and safety study of ondansetron inhalation powder for postoperative nausea and vomiting has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Luxena Pharmaceuticals, Inc. | Conditions: Postoperative Nausea and Vomiting | Phase 1 | Status: COMPLETED